US Stock MarketDetailed Quotes

UroGen Pharma Ltd (URGN)

Watchlist
  • 23.000
  • -0.830-3.48%
Close May 1 15:59 ET
  • 22.800
  • -0.200-0.87%
Post 20:01 ET
1.12BMarket Cap-7.21P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

UroGen Pharma Ltd (URGN) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
21.45%109.79M
54.03%37.84M
9.04%27.48M
10.83%24.22M
7.84%20.25M
9.29%90.4M
4.40%24.57M
20.87%25.2M
3.35%21.85M
9.24%18.78M
Operating revenue
21.45%109.79M
54.03%37.84M
9.04%27.48M
10.83%24.22M
7.84%20.25M
9.29%90.4M
4.40%24.57M
20.87%25.2M
3.35%21.85M
9.24%18.78M
Cost of revenue
40.15%12.45M
33.10%3.29M
33.63%3.28M
59.26%3.55M
34.84%2.33M
-5.13%8.88M
8.09%2.47M
3.63%2.45M
-8.76%2.23M
-23.71%1.73M
Gross profit
19.41%97.34M
56.37%34.55M
6.39%24.2M
5.33%20.67M
5.11%17.92M
11.13%81.52M
4.00%22.09M
23.08%22.75M
4.94%19.62M
14.24%17.05M
Operating expense
24.62%222.2M
7.86%53.66M
28.03%51.59M
36.64%62.11M
28.15%54.84M
28.38%178.3M
38.77%49.75M
25.98%40.3M
33.39%45.46M
15.74%42.79M
Selling and administrative expenses
28.02%155.1M
12.88%39.35M
29.86%37.58M
43.73%43.2M
28.09%34.97M
29.89%121.15M
41.98%34.86M
33.03%28.94M
33.62%30.06M
11.54%27.3M
Research and development costs
17.43%67.11M
-3.89%14.31M
23.36%14.01M
22.80%18.91M
28.25%19.87M
25.28%57.15M
31.78%14.89M
11.00%11.36M
32.96%15.4M
23.97%15.49M
Operating profit
-29.01%-124.86M
30.89%-19.12M
-56.09%-27.39M
-60.41%-41.45M
-43.41%-36.91M
-47.68%-96.78M
-89.32%-27.66M
-29.96%-17.55M
-67.98%-25.84M
-16.76%-25.74M
Net non-operating interest income expense
-3.15%-27.88M
-5.26%-7.52M
-15.97%-6.82M
7.81%-7.1M
-2.19%-6.45M
19.61%-27.03M
14.61%-7.14M
30.50%-5.88M
11.19%-7.7M
22.42%-6.31M
Non-operating interest income
-32.99%5.97M
-67.71%908K
-57.34%1.18M
9.32%1.68M
22.58%2.2M
237.03%8.9M
287.33%2.81M
230.18%2.76M
252.64%1.53M
178.76%1.8M
Non-operating interest expense
22.55%15.35M
-3.08%3.77M
23.96%3.37M
19.39%4.13M
66.24%4.07M
-14.91%12.52M
8.53%3.89M
-28.68%2.72M
-7.98%3.46M
-31.13%2.45M
Total other finance cost
-20.96%18.5M
-23.22%4.66M
-21.88%4.62M
-19.56%4.64M
-19.03%4.58M
8.63%23.41M
10.14%6.06M
7.96%5.92M
8.03%5.77M
8.35%5.66M
Other net income (expense)
-192.58%-670K
91.94%-5K
-24.68%-197K
-317.24%-378K
50.82%-90K
-127.33%-229K
-107.64%-62K
-322.54%-158K
680.00%174K
-1,120.00%-183K
Gain on sale of security
----
----
21.88%-4.62M
19.56%-4.64M
19.03%-4.58M
-8.63%-23.41M
-10.14%-6.06M
-7.96%-5.92M
-8.03%-5.77M
-8.35%-5.66M
Other non- operating income (expenses)
-192.58%-670K
91.94%-5K
-24.68%-197K
-317.24%-378K
50.82%-90K
-127.33%-229K
-107.64%-62K
-322.54%-158K
680.00%174K
-1,120.00%-183K
Income before tax
-23.68%-153.42M
23.59%-26.64M
-45.88%-34.4M
-46.64%-48.93M
-34.81%-43.45M
-26.16%-124.04M
-57.31%-34.86M
-7.74%-23.58M
-38.55%-33.37M
-6.76%-32.23M
Income tax
-97.25%78K
-110.38%-275K
-1,258.24%-1.05M
2,571.05%1.02M
625.93%392K
-27.76%2.83M
-31.27%2.65M
1,111.11%91K
-29.63%38K
157.14%54K
Net income
-20.98%-153.49M
29.72%-26.36M
-40.87%-33.35M
-49.51%-49.94M
-35.80%-43.84M
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
Net income continuous Operations
-20.98%-153.49M
29.72%-26.36M
-40.87%-33.35M
-49.51%-49.94M
-35.80%-43.84M
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
Minority interest income
Net income attributable to the parent company
-20.98%-153.49M
29.72%-26.36M
-40.87%-33.35M
-49.51%-49.94M
-35.80%-43.84M
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-20.98%-153.49M
29.72%-26.36M
-40.87%-33.35M
-49.51%-49.94M
-35.80%-43.84M
-24.09%-126.87M
-44.19%-37.51M
-8.20%-23.67M
-38.39%-33.4M
-6.86%-32.29M
Basic earnings per share
-7.77%-3.19
32.50%-0.54
-35.29%-0.69
-28.05%-1.05
-5.75%-0.92
16.62%-2.96
-21.21%-0.8
25.00%-0.51
20.39%-0.82
33.08%-0.87
Diluted earnings per share
-7.77%-3.19
32.50%-0.54
-35.29%-0.69
-28.05%-1.05
-5.75%-0.92
16.62%-2.96
-21.21%-0.8
25.00%-0.51
20.39%-0.82
33.08%-0.87
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 21.45%109.79M54.03%37.84M9.04%27.48M10.83%24.22M7.84%20.25M9.29%90.4M4.40%24.57M20.87%25.2M3.35%21.85M9.24%18.78M
Operating revenue 21.45%109.79M54.03%37.84M9.04%27.48M10.83%24.22M7.84%20.25M9.29%90.4M4.40%24.57M20.87%25.2M3.35%21.85M9.24%18.78M
Cost of revenue 40.15%12.45M33.10%3.29M33.63%3.28M59.26%3.55M34.84%2.33M-5.13%8.88M8.09%2.47M3.63%2.45M-8.76%2.23M-23.71%1.73M
Gross profit 19.41%97.34M56.37%34.55M6.39%24.2M5.33%20.67M5.11%17.92M11.13%81.52M4.00%22.09M23.08%22.75M4.94%19.62M14.24%17.05M
Operating expense 24.62%222.2M7.86%53.66M28.03%51.59M36.64%62.11M28.15%54.84M28.38%178.3M38.77%49.75M25.98%40.3M33.39%45.46M15.74%42.79M
Selling and administrative expenses 28.02%155.1M12.88%39.35M29.86%37.58M43.73%43.2M28.09%34.97M29.89%121.15M41.98%34.86M33.03%28.94M33.62%30.06M11.54%27.3M
Research and development costs 17.43%67.11M-3.89%14.31M23.36%14.01M22.80%18.91M28.25%19.87M25.28%57.15M31.78%14.89M11.00%11.36M32.96%15.4M23.97%15.49M
Operating profit -29.01%-124.86M30.89%-19.12M-56.09%-27.39M-60.41%-41.45M-43.41%-36.91M-47.68%-96.78M-89.32%-27.66M-29.96%-17.55M-67.98%-25.84M-16.76%-25.74M
Net non-operating interest income expense -3.15%-27.88M-5.26%-7.52M-15.97%-6.82M7.81%-7.1M-2.19%-6.45M19.61%-27.03M14.61%-7.14M30.50%-5.88M11.19%-7.7M22.42%-6.31M
Non-operating interest income -32.99%5.97M-67.71%908K-57.34%1.18M9.32%1.68M22.58%2.2M237.03%8.9M287.33%2.81M230.18%2.76M252.64%1.53M178.76%1.8M
Non-operating interest expense 22.55%15.35M-3.08%3.77M23.96%3.37M19.39%4.13M66.24%4.07M-14.91%12.52M8.53%3.89M-28.68%2.72M-7.98%3.46M-31.13%2.45M
Total other finance cost -20.96%18.5M-23.22%4.66M-21.88%4.62M-19.56%4.64M-19.03%4.58M8.63%23.41M10.14%6.06M7.96%5.92M8.03%5.77M8.35%5.66M
Other net income (expense) -192.58%-670K91.94%-5K-24.68%-197K-317.24%-378K50.82%-90K-127.33%-229K-107.64%-62K-322.54%-158K680.00%174K-1,120.00%-183K
Gain on sale of security --------21.88%-4.62M19.56%-4.64M19.03%-4.58M-8.63%-23.41M-10.14%-6.06M-7.96%-5.92M-8.03%-5.77M-8.35%-5.66M
Other non- operating income (expenses) -192.58%-670K91.94%-5K-24.68%-197K-317.24%-378K50.82%-90K-127.33%-229K-107.64%-62K-322.54%-158K680.00%174K-1,120.00%-183K
Income before tax -23.68%-153.42M23.59%-26.64M-45.88%-34.4M-46.64%-48.93M-34.81%-43.45M-26.16%-124.04M-57.31%-34.86M-7.74%-23.58M-38.55%-33.37M-6.76%-32.23M
Income tax -97.25%78K-110.38%-275K-1,258.24%-1.05M2,571.05%1.02M625.93%392K-27.76%2.83M-31.27%2.65M1,111.11%91K-29.63%38K157.14%54K
Net income -20.98%-153.49M29.72%-26.36M-40.87%-33.35M-49.51%-49.94M-35.80%-43.84M-24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M
Net income continuous Operations -20.98%-153.49M29.72%-26.36M-40.87%-33.35M-49.51%-49.94M-35.80%-43.84M-24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M
Minority interest income
Net income attributable to the parent company -20.98%-153.49M29.72%-26.36M-40.87%-33.35M-49.51%-49.94M-35.80%-43.84M-24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -20.98%-153.49M29.72%-26.36M-40.87%-33.35M-49.51%-49.94M-35.80%-43.84M-24.09%-126.87M-44.19%-37.51M-8.20%-23.67M-38.39%-33.4M-6.86%-32.29M
Basic earnings per share -7.77%-3.1932.50%-0.54-35.29%-0.69-28.05%-1.05-5.75%-0.9216.62%-2.96-21.21%-0.825.00%-0.5120.39%-0.8233.08%-0.87
Diluted earnings per share -7.77%-3.1932.50%-0.54-35.29%-0.69-28.05%-1.05-5.75%-0.9216.62%-2.96-21.21%-0.825.00%-0.5120.39%-0.8233.08%-0.87
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +17.90%
Sample Name
Sample Code
 +13.59%
Sample Name
Sample Code
 +12.81%
4
VanEck Oil Services ETF
OIH
+11.45%
5
United Sts 12 Month Oil Fd Lp Unit Ben Int
USL
+9.96%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +11.87%
Sample Name
Sample Code
 +6.69%
Sample Name
Sample Code
 +6.27%
4
KE Holdings
BEKE
+5.44%
5
New Oriental
EDU
+4.10%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 1, the more than two-month-long military conflict involving the US, Israel, and Iran will reach a legal milestone, potentially increa Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -